Optic Neuritis & Demyelinating Disease

Overview

Optic neuritis is inflammatory demyelination of the optic nerve. It is the presenting symptom of multiple sclerosis in a substantial fraction of patients who go on to be diagnosed with MS. The classic patient is a young adult, typically a woman in her twenties or thirties, with subacute unilateral vision loss developing over hours to days and periocular pain that worsens with eye movement.

Whether the optic disc looks swollen on exam depends on where along the nerve the inflammation sits. An anterior lesion, near the disc, produces visible disc edema (papillitis). Inflammation further back, retrobulbar optic neuritis, leaves the disc looking completely normal even though the patient's vision is markedly reduced. This mismatch is captured in the classic teaching aphorism: "the patient sees nothing, and the doctor sees nothing." Either way, an afferent pupillary defect (relative or absolute) on the affected side is expected: the pathology is unilateral conduction failure along the optic nerve itself.

Clinical Features

The two features that, together, point most specifically at optic neuritis rather than an ischemic or compressive optic neuropathy are the pattern of vision loss and the pain.

• Central scotoma. The inflammation preferentially affects the central fibers responsible for high-acuity, fixation vision, so the visual field defect is characteristically a central scotoma. That's distinct from the altitudinal defects typical of ischemic optic neuropathy or the more peripheral, vertical-meridian-respecting defects of a compressive or chiasmal lesion.
• Pain with eye movement. Retro-orbital pain that worsens with eye movement is characteristic of optic neuritis. It comes from the inflamed optic nerve sheath being pulled taut against the extraocular muscle cone as the globe rotates, a mechanical consequence of the anatomy rather than a separate disease process. This pain is one of the more useful bedside clues for distinguishing optic neuritis from ischemic causes, which are classically painless.

Color vision, particularly red-green discrimination, and contrast sensitivity are often disproportionately affected relative to visual acuity. This pattern is shared with several other toxic, nutritional, and hereditary optic neuropathies, but it's worth checking specifically here: dyschromatopsia can be the most sensitive early sign of nerve dysfunction.

Diagnosis & MRI

Brain MRI with T2/FLAIR sequences is the key imaging study in acute optic neuritis. Its purpose is less about confirming the optic nerve diagnosis, which is usually clinical, than about risk-stratifying for multiple sclerosis. Periventricular white matter lesions on brain MRI at the time of the attack are the single strongest predictor of subsequent conversion to clinically definite MS. A normal brain MRI at presentation carries a substantially lower long-term MS risk than even a few demyelinating-appearing lesions already present.

This is why the diagnostic workup of optic neuritis is inseparable from the question of MS risk: the MRI findings shape counseling, follow-up intensity, and in some cases the decision to start disease-modifying therapy earlier rather than waiting for a second clinical attack.

The Optic Neuritis Treatment Trial

The Optic Neuritis Treatment Trial (ONTT) is the landmark study defining how acute optic neuritis is treated. Its most quoted, and most frequently misunderstood, finding concerns oral steroids specifically: oral prednisone alone was harmful, roughly doubling the rate of new optic neuritis attacks compared with placebo rather than helping. Oral corticosteroid monotherapy is avoided in acute optic neuritis for this reason.

Intravenous methylprednisolone, by contrast, speeds visual recovery: patients who received IV steroids regained vision faster than those simply observed. The ONTT also found that IV steroids did not change the final visual outcome at long-term follow-up compared with observation alone. The benefit is in the speed of recovery, not the ceiling of how much vision ultimately returns. In practice, IV methylprednisolone, sometimes followed by an oral taper (which does not carry oral monotherapy's attack-rate risk), is used when faster recovery is clinically desired, while observation alone remains reasonable for milder cases.

Uhthoff Phenomenon

Uhthoff phenomenon is the transient worsening of visual, or other neurologic, function in a demyelinated pathway when core body temperature rises: a hot shower, exercise, or fever can all trigger it. Conduction along a demyelinated axon is already impaired, so even a small further slowing of nerve conduction from heat can push a marginal pathway into functional block, producing symptoms that resolve once temperature normalizes. It's typically seen in patients with a prior episode of optic neuritis rather than during the acute attack itself, and its presence is a useful historical clue pointing toward an underlying demyelinating process.

Related Topics

Continue exploring Neuro-ophthalmology: